Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,798,018
-
Total 13F shares
-
41,458,638
-
Share change
-
-73,325
-
Total reported value
-
$4,187,802,157
-
Put/Call ratio
-
51%
-
Price per share
-
$101.00
-
Number of holders
-
314
-
Value change
-
-$27,033,050
-
Number of buys
-
159
-
Number of sells
-
167
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q3 2020
As of 30 Sep 2020,
UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by
314 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,458,638 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, STATE STREET CORP, ACADIAN ASSET MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., AQR CAPITAL MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, and FIRST TRUST ADVISORS LP.
This page lists
316
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.